Emerging clinical and research approaches in targeted therapies for high-risk neuroblastoma
Neuroblastoma is a pediatric cancer that originates from neural crest cells and is the most common extracranial solid tumor in children under five years of age. While low-risk neuroblastoma often regresses spontaneously, high-risk neuroblastoma poses a significant clinical challenge. Recent advances...
Saved in:
| Main Authors: | Albatool AlKhazal, Samiha Chohan, Destani J. Ross, Jinhwan Kim, Erin G. Brown |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1553511/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metronomic chemotherapy in pediatric neuroblastoma
by: Yi Jiang, et al.
Published: (2024-12-01) -
Emerging frontiers in epigenetic-targeted therapeutics for pediatric neuroblastoma
by: Xiaokang Wang, et al.
Published: (2025-07-01) -
Comprehensive health status and health-related quality of life of children at diagnosis of high-risk neuroblastoma: a multicentric pilot study
by: Karina Viani, et al.
Published: (2024-12-01) -
Role and practical guidelines for the use of radiotherapy in neuroblastoma — a narrative review of literature and clinical trial protocols
by: Aleksandra Jadwiga Sztuder, et al.
Published: (2025-01-01) -
Metastatic Neuroblastoma Masquerading as Ewing’s Sarcoma on X-ray: An Imaging Puzzle in Pediatric Oncology
by: Mukesh Kumar, et al.
Published: (2025-01-01)